KRAS mutation is not associated with recurrence or survival in 508 stage III colon cancers: Findings from multicenter adjuvant trial CALGB 89803 Ogino, S. , Meyerhardt, J. A. , Irahara, N. , Niedzwiecki, D. ... - AMP - Annual Meeting Association of Molecular Pathology - 2009 Abstract - Secondary Endpoint - Primary Analysis - GI - C89803
